As pharmaceutical ingenuity hits new heights, ensuring that patients gain access to innovative medicines requires a unique combination of evidence generation and communication
Canadian start-up AccessNow has won first prize in a Novartis competition to find technological ways to help people with multiple sclerosis lead independent lives.
Alexander Gray and Mike Rea from IDEA Pharma explain why the current pharma R&D model is broken, and how it’s hindering commercialisation for companies across the industry